Selective Cyclo-Oxygenase-2 Inhibitors and Myocardial Infarction
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 25 (12) , 829-835
- https://doi.org/10.2165/00002018-200225120-00001
Abstract
There are concerns that selective cyclo-oxygenase (COX)-2 inhibitors may be prothrombotic and increase the risk of myocardial infarction. This has largely arisen because of an unexpected finding of a...Keywords
This publication has 22 references indexed in Scilit:
- Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis.Archives of internal medicine (1960), 2002
- Association between naproxen use and protection against acute myocardial infarction.Archives of internal medicine (1960), 2002
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort studyThe Lancet, 2002
- COX-2 Specific Inhibitors in the Management of Osteoarthritis of the Knee: A Placebo-Controlled, Randomized, Double-Blind StudyJCR: Journal of Clinical Rheumatology, 2001
- Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trialsHeart, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Cyclooxygenase Inhibition Converts the Effect of Nitric Oxide Synthase Inhibition from Infarct Size Reduction to Expansion in Isolated Rabbit HeartsJournal of Molecular and Cellular Cardiology, 1999
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998